EGFR and lung adenocarcinoma: For patients with early-stage lung adenocarcinoma, curative surgery is the standard treatment [5,6,7,8]; some studies have pointed out that patients with early-stage lung adenocarcinoma with EGFR mutations have a lower recurrence rate after surgery [9,10].